Structural and functional remodeling of the heart in hypertensive patients with COVID-19: assessmentof changes at the end of hospitalization period and during a 1-month follow-up

Main Article Content

O.V. Honchar

Abstract

COVID-19 is often accompanied by the long-term persistence of symptoms, the risk of which depends on the severity and duration of the acute phase, as well as existing comorbidities. Cardiac dysfunction is one of the possible mechanisms of impaired functional status of patients. While clinically manifest systolic heart failure is a rare phenomenon in such a situation, minor alterations in the structural and functional state of the heart may be contributing to persistence of general symptoms such as dyspnea, fatigue, and reduced work capacity.
The aim – to study the role of hypertension in the formation of structural and functional changes of the heart during hospitalization for COVID-19, and the dynamics of detected changes in the early period after discharge.
Materials and methods. 221 hospitalized patients with COVID-19 (age 53.4±13.6 years, 53 % female) underwent a comprehensive transthoracic echocardiographic examination 1-2 days before discharge and after 31 days of follow-up. The control group included 88 subjects matched by age, sex, height, weight, and existing comorbidities. The studied parameters included morphometry of the cardiac chambers, indices of longitudinal systolic function and diastolic filling of the ventricles; the participants were also performing a 6-minute walk test.
Results. Geometric changes of the heart in hospitalized patients with COVID-19 at the time of discharge included an increase in absolute (10.1±1.5 vs 9.1±0.9 mm, p<0.001) and relative LV walls thickness (0.45±0,07 vs 0.39±0.04, p<0.001), indices of LV myocardial mass (38.1±8.9 vs 33.9±5.8 g/m2.7, p<0.001) and left atrial volume index (28.6±6.6 vs 25.1±4.9 ml/m2, p<0.001), as well as a decrease in LV global longitudinal strain (-17.5±2.4 vs -18.6±2.2 %, p<0.001) and diastolic filling parameters (e’ – 9.2±2.2 vs 11.3±2.6 cm/s, p<0.001; E/e’ – 7.5±1.8 vs 6.8±1.7, p=0.002). The observed changes were more pronounced in the cohort of hypertensive participants, but also persisted in normotensive patients, resulting in a high prevalence of concentric LV geometry (78 % and 43 %, respectively, p<0.001 between groups and vs controls), mainly type I diastolic dysfunction (51 % and 25 %, p<0.001 between groups and vs control), as well as abnormal values of global longitudinal strain (32 % and 19 %, p=0.027 between groups, p<0.001 vs control), which persisted during a short observation period. The increase in the reached % of individually predicted 6-minute walk distance was 11.2±7.5 in hypertensive participants vs 12.8±7.6 in normotensives, p>0.05.
Conclusions. Patients with COVID-19 at the end of hospitalization period were characterized by a high prevalence of LV concentric geometry and diastolic dysfunction, as well as minor decrease in its longitudinal systolic function, which were more pronounced in the presence of concomitant hypertension and did not improve during the first month after discharge.

Article Details

Keywords:

COVID-19, post-COVID syndrome, echocardiography, cardiac remodeling, diastolic dysfunction.

References

https://www.worldometers.info/coronavirus/worldwide-graphs/. Accessed 01.03.2023.

Doroftei B, Ciobica A, Ilie OD, Maftei R, Ilea C. Mini-Review Discussing the Reliability and Efficiency of COVID-19 Vaccines. Diagnostics (Basel). 2021;11. https://doi.org/10.3390/diagnostics11040579

Gyongyosi M, Alcaide P, Asselbergs FW, Brundel B, Camici GG, da Costa Martins P, et al. Long COVID and the cardiovascular system - elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: A joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial & Pericardial Diseases. Cardiovasc Res. 2022. https://doi.org/10.1093/cvr/cvac115

Herrera JE, Niehaus WN, Whiteson J, Azola A, Baratta JM, Fleming TK, et al. Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of fatigue in postacute sequelae of SARS-CoV-2 infection (PASC) patients. PM R. 2021;13:1027-43. https://doi.org/10.1002/pmrj.12684

Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, Condition WHOCCDWGoP-C-. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102-e107. https://doi.org/10.1016/S1473-3099(21)00703-9

NICE. COVID-19 rapid guideline: managing the long-term effects of COVID-19. In: COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: 2020.

Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417-18. https://doi.org/10.1016/S0140-6736(20)30937-5 .

Petersen SE, Friedrich MG, Leiner T, Elias MD, Ferreira VM, Fenski M, et al. Cardiovascular Magnetic Resonance for Patients With COVID-19. JACC Cardiovasc Imaging. 2022;15:685-99. https://doi.org/10.1016/j.jcmg.2021.08.021.

Hu Y, Sun J, Dai Z, Deng H, Li X, Huang Q, et al. Prevalence and severity of corona virus disease 2019 (COVID-19): A systematic review and meta-analysis. J Clin Virol. 2020;127:104371. https://doi.org/10.1016/j.jcv.2020.104371.

Garg S, Kim L, Whitaker M, O’Halloran A, Cummings C, Holstein R, et al. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Corona­­virus Disease 2019 – COVID-NET, 14 States, March 1-30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:458-64. https://doi.org/10.15585/mmwr.mm6915e3.

Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020;323:2052-9. https://doi.org/10.1001/jama.2020.6775.

Marwick TH, Gillebert TC, Aurigemma G, Chirinos J, Derumeaux G, Galderisi M, et al. Recommendations on the Use of Echocardiography in Adult Hypertension: A Report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). J Am Soc Echocardiogr. 2015;28:727-54. https://doi.org/10.1016/j.echo.2015.05.002.

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599-726. https://doi.org/10.1093/eurheartj/ehab368.

World Health Organization (WHO). COVID-19 Clinical management: living guidance, 25.01.2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1.

Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16:233-70. https://doi.org/10.1093/ehjci/jev014.

Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29:277-314. https://doi.org/10.1016/j.echo.2016.01.011.

Aurich M, Fuchs P, Muller-Hennessen M, Uhlmann L, Niemers M, Greiner S, et al. Unidimensional Longitudinal Strain: A Simple Approach for the Assessment of Longitudinal Myocardial Deformation by Echocardiography. J Am Soc Echocardiogr. 2018;31:733-42. https://doi.org/10.1016/j.echo.2017.12.010.

Stoylen A, Molmen HE, Dalen H. Relation between Mitral Annular Plane Systolic Excursion and Global longitudinal strain in normal subjects: The HUNT study. Echocardiography. 2018;35:603-10. https://doi.org/10.1111/echo.13825.

Stoylen A, Molmen HE, Dalen H. Left ventricular global strains by linear measurements in three dimensions: interrelations and relations to age, gender and body size in the HUNT Study. Open Heart. 2019;6:e001050. https://doi.org/10.1136/openhrt-2019-001050.

Mahmoud-Elsayed HM, Moody WE, Bradlow WM, Khan-Kheil AM, Senior J, Hudsmith LE, et al. Echocardiographic Findings in Patients With COVID-19 Pneumonia. Can J Cardiol. 2020;36:1203-7. https://doi.org/10.1016/j.cjca.2020.05.030.

Szekely Y, Lichter Y, Taieb P, Banai A, Hochstadt A, Merdler I, et al. Spectrum of Cardiac Manifestations in COVID-19: A Systematic Echocardiographic Study. Circulation. 2020;142:342-53. https://doi.org/10.1161/CIRCULATIONAHA.120.047971.

Erdei T, Smiseth OA, Marino P, Fraser AG. A systematic review of diastolic stress tests in heart failure with preserved ejection fraction, with proposals from the EU-FP7 MEDIA study group. Eur J Heart Fail. 2014;16:1345-61. https://doi.org/10.1002/ejhf.184.

Raman B, Bluemke DA, Luscher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. 2022;43:1157-72. https://doi.org/10.1093/eurheartj/ehac031.

Moody WE, Liu B, Mahmoud-Elsayed HM, Senior J, Lalla SS, Khan-Kheil AM, et al. Persisting Adverse Ventricular Remodeling in COVID-19 Survivors: A Longitudinal Echocardiographic Study. J Am Soc Echocardiogr. 2021;34:562-6. https://doi.org/10.1016/j.echo.2021.01.020.

Li Y, Li H, Zhu S, Xie Y, Wang B, He L, et al. Prognostic Value of Right Ventricular Longitudinal Strain in Patients With COVID-19. JACC Cardiovasc Imaging. 2020;13:2287-2299. https://doi.org/10.1016/j.jcmg.2020.04.014.

Catena C, Colussi G, Bulfone L, Da Porto A, Tascini C, Sechi LA. Echocardiographic Comparison of COVID-19 Patients with or without Prior Biochemical Evidence of Cardiac Injury after Recovery. J Am Soc Echocardiogr. 2021;34:193-5. https://doi.org/10.1016/j.echo.2020.10.009.

Sechi LA, Colussi G, Bulfone L, Brosolo G, Da Porto A, Peghin M, et al. Short-term cardiac outcome in survivors of COVID-19: a systematic study after hospital discharge. Clin Res Cardiol. 2021;110:1063-72. https://doi.org/10.1007/s00392-020-01800-z.

Ingul CB, Grimsmo J, Mecinaj A, Trebinjac D, Berger Nossen M, Andrup S, et al. Cardiac Dysfunction and Arrhythmias 3 Months After Hospitalization for COVID-19. J Am Heart Assoc. 2022;11:e023473. https://doi.org/10.1161/JAHA.121.023473.

Ovrebotten T, Myhre P, Grimsmo J, Mecinaj A, Trebinjac D, Nossen MB, et al. Changes in cardiac structure and function from 3 to 12 months after hospitalization for COVID-19. Clin Cardiol. 2022;45:1044-52. https://doi.org/10.1002/clc.23891.

Most read articles by the same author(s)

<< < 10 11 12 13 14 15 16 17 18 19 > >>